Investor Explains Decision to Cash Out on Growth ETF While Maintaining Long-Term Optimism
Amplius Wealth's Share Sale: Amplius Wealth Advisors sold 75,079 shares of the iShares Core S&P U.S. Growth ETF (IUSG) for approximately $11.8 million, representing about 1% of its 13F assets under management, while retaining 43,598 shares valued at $7.2 million.
Portfolio Adjustment Strategy: The sale is part of a broader portfolio adjustment rather than a complete shift away from growth investing, as Amplius continues to hold significant positions in growth-oriented ETFs, including its flagship Amplius Aggressive Asset Allocation ETF (AAAA).
Market Performance Context: IUSG shares have increased by 24.5% over the past year, outperforming the S&P 500's nearly 17% rise, highlighting the fund's focus on U.S. growth equities and its diversified investment strategy.
Risk Management Approach: Amplius Wealth's adjustments signal a cautious approach to balancing risk after a strong equity rally, indicating a recalibration of risk levels while maintaining core growth allocations amidst rising valuations and elevated interest rates.
Trade with 70% Backtested Accuracy
Analyst Views on IUSG

No data
About the author

Market Volatility and Economic Outlook: The S&P 500 has experienced a 3.7% decline in November, but upgraded growth forecasts and strong earnings from AI adoption suggest a positive economic trajectory, with expectations for a Fed rate cut in December bolstering investor sentiment.
Performance of Growth vs. Value Indices: Over the past year, the S&P 500 Growth Index has significantly outperformed the S&P 500 Value Index, with returns of 18.86% compared to 1.83%, indicating a strong preference for growth stocks among investors.
Institutional Forecasts for S&P 500: Morgan Stanley and UBS have raised their forecasts for the S&P 500, predicting it will reach 7,800 and 7,500 by the end of 2026 and 2024, respectively, driven by strong corporate earnings and AI advancements.
Investor Inflows into Equity Funds: U.S. equity funds have seen consistent inflows, totaling $4.36 billion in the week ending Nov. 19, as investors focus on robust third-quarter earnings and overlook concerns about tech valuations.
ETF Analysis: The iShares Core S&P U.S. Growth ETF (IUSG) has an implied analyst target price of $188.85, indicating a potential upside of 10.66% from its current trading price of $170.65.
Notable Holdings: Key underlying holdings with significant upside potential include Saia Inc (18.16% upside), Silicon Laboratories Inc (17.74% upside), and Parsons Corp (14.26% upside) based on their respective analyst target prices.
Market Sentiment: The disparity between current trading prices and analyst target prices raises questions about whether analysts are overly optimistic or if their targets are justified based on recent developments.
Investor Considerations: Investors are encouraged to conduct further research to assess the validity of analyst targets and the potential for price adjustments in light of market conditions.

Amplius Wealth's Share Sale: Amplius Wealth Advisors sold 75,079 shares of the iShares Core S&P U.S. Growth ETF (IUSG) for approximately $11.8 million, representing about 1% of its 13F assets under management, while retaining 43,598 shares valued at $7.2 million.
Portfolio Adjustment Strategy: The sale is part of a broader portfolio adjustment rather than a complete shift away from growth investing, as Amplius continues to hold significant positions in growth-oriented ETFs, including its flagship Amplius Aggressive Asset Allocation ETF (AAAA).
Market Performance Context: IUSG shares have increased by 24.5% over the past year, outperforming the S&P 500's nearly 17% rise, highlighting the fund's focus on U.S. growth equities and its diversified investment strategy.
Risk Management Approach: Amplius Wealth's adjustments signal a cautious approach to balancing risk after a strong equity rally, indicating a recalibration of risk levels while maintaining core growth allocations amidst rising valuations and elevated interest rates.
ETF Analysis: The iShares Core S&P U.S. Growth ETF (IUSG) has an implied analyst target price of $179.84, indicating a potential upside of 10.64% from its current trading price of $162.54.
Notable Holdings: Key underlying holdings with significant upside potential include Commerce Bancshares Inc (CBSH), Crane NXT Co (CXT), and Belden Inc (BDC), with expected price increases of 16.26%, 14.74%, and 12.78% respectively based on analyst targets.
ETF Target Price Analysis: The iShares Core S&P U.S. Growth ETF (IUSG) has an implied analyst target price of $178.40, indicating a potential upside of 10.53% from its current trading price of $161.40.
Notable Holdings with Upside: Key underlying holdings such as Targa Resources Corp (TRGP), Equitable Holdings Inc (EQH), and Range Resources Corp (RRC) show significant upside potential, with target prices suggesting increases of 25.54%, 24.24%, and 24.20% respectively from their recent trading prices.
iShares Russell 3000 Growth ETF (IUSG) Overview
- ETF Characteristics: The iShares Russell 3000 Growth ETF (IUSG) is categorized as a Large-Cap Momentum ETF, primarily focusing on growth-oriented investments.
- Sector Allocation: The largest sector represented in IUSG's portfolio is Technology, with Business Services being the most significant industry within that sector.
Factor Exposure Analysis
- Investment Factors: The ETF's exposure to major investing factors such as value, quality, momentum, and low volatility is assessed, with scores ranging from 1 to 99. A score of 99 indicates the highest exposure to a particular factor.
Additional Resources
- Research Links: The report provides links to additional resources, including lists of top Technology ETFs, High Momentum ETFs, Top Low Volatility ETFs, and High Fundamental Momentum ETFs.
- Validea's Role: Validea is an investment research service that analyzes stock performance based on strategies from renowned investors like Warren Buffett and Benjamin Graham, offering insights and model portfolios.
Disclaimer
- Author's Views: The opinions expressed in the report are those of the author and do not necessarily reflect the views of Nasdaq, Inc.










